The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

JCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard… - The Lancet, 2020 - thelancet.com
Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

Cost-effectiveness of interventions to manage diabetes: has the evidence changed since 2008?

KR Siegel, MK Ali, X Zhou, BP Ng, S Jawanda… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE To synthesize updated evidence on the cost-effectiveness (CE) of interventions
to manage diabetes, its complications, and comorbidities. RESEARCH DESIGN AND …

Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review

R Li, P Zhang, LE Barker, FM Chowdhury… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE To synthesize the cost-effectiveness (CE) of interventions to prevent and control
diabetes, its complications, and comorbidities. RESEARCH DESIGN AND METHODS We …

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

B Hemmingsen, SS Lund, C Gluud… - Cochrane Database …, 2013 - cochranelibrary.com
Background Patients with type 2 diabetes mellitus (T2D) have an increased risk of
cardiovascular disease and mortality compared to the background population …

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

B Hemmingsen, SS Lund, C Gluud, A Vaag, T Almdal… - Bmj, 2011 - bmj.com
Objective To assess the effect of targeting intensive glycaemic control versus conventional
glycaemic control on all cause mortality and cardiovascular mortality, non-fatal myocardial …

The burden of type 2 diabetes: are we doing enough?

P Zimmet - Diabetes & metabolism, 2003 - Elsevier
Increasing levels of obesity, arising from energy-rich diets and sedentary lifestyles, are
driving a global pandemic of type 2 diabetes. The prevalence of type 2 diabetes worldwide …

Diet and risk of coronary heart disease and type 2 diabetes

JI Mann - The Lancet, 2002 - thelancet.com
A high intake of saturated fat is an important risk factor for coronary heart disease (CHD) and
type 2 diabetes. However the declining rates of CHD in many affluent societies and the …

Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway

X Hou, J Song, XN Li, L Zhang, XL Wang… - Biochemical and …, 2010 - Elsevier
Background: Oxidative stress induced by free fatty acids plays a critical role in the
pathogenesis of endothelial dysfunction and atherosclerosis in patients with metabolic …

Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a …

J Sidorov, R Shull, J Tomcavage, S Girolami… - Diabetes …, 2002 - Am Diabetes Assoc
OBJECTIVE—Little is known about the impact of disease management programs on medical
costs for patients with diabetes. This study compared health care costs for patients who …

Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol®) effectively inhibit α-glucosidase

A Schäfer, P Högger - Diabetes Research and Clinical Practice, 2007 - Elsevier
The standardized maritime pine bark extract (Pycnogenol®) was reported to exert clinical
anti-diabetic effects after peroral intake. However, an increased insulin secretion was not …